Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu
Beginning today, Hong Kong people and their children will have direct access to Filligent"s patented anti- microbial face mask, the BioMask(TM). The revolutionary mask, which traps and kills germs like H1N1 upon contact, was launched at Asia"s leading drugstore chain, Watsons, today. In addition, Hong Kong"s biggest travel agency, Hong Thai, will be providing the BioMask(TM), on a complimentary basis, to all air travelers through the end of August. Up until now, the CE-certified, specialist mask has only been available to medical and healthcare professionals. The launch and availability of the BioMask(TM) in consumer retailers and service providers is significant because, as CEO Melissa Mowbray-d"Arbela says, "The BioMask(TM) is the first "intelligent" face mask. You don"t have to be a health care worker or medical professional to use it correctly. Instead, the mask is very easy to put on, wear and dispose of properly. Thus, it"s one of the best forms of protection for ordinary people and their children during this year"s swine flu crisis."
generic viagra online
Lutonix, Inc. Announces First Patient Enrollments In Three Separate Clinical Trials
Lutonix, Inc., a privately held medical device start-up, announced that patient enrollment is underway for its three simultaneous first-in-human clinical trials. The three studies are designed to test whether the proprietary Lutonix Drug Coated Balloon (DCB) Catheter is safe and effective in the treatment of vascular narrowing.
News of the day
Cadence Pharmaceuticals Submits Acetavance New Drug Application For The Treatment Of Acute Pain And Fever
Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), for the treatment of acute pain and fever in adults and children. If approved, Acetavance would become the first new intravenous analgesic approved in the United States in more than 20 years and the only approved intravenous agent for the treatment of fever in the United States.
Health Insurance

Wanted - PCTs To Get Involved In Groundbreaking User Involvement Project, UK

Diabetes UK and NHS Diabetes have joined forces to deliver an innovative project that will support three primary care trusts (PCTs) in England to develop effective user involvement approaches in diabetes care. The charity is now seeking three organisations to become our local partners. About the project The "User involvement in local diabetes care" project will develop partnerships locally to create and support structured, systematic and sustainable user involvement in all aspects of diabetes care. User involvement allows people living with diabetes to influence the decisions taken about the services the NHS provides. These partnerships will provide support tailored to local need. In the later stages the project will share learning and good practice examples with services across the UK. Express your interest in taking part Initial expressions of interest to take part in the project must be submitted by 31 July 2009 - use our online form to express your interest. An innovative project "We want to make sure that the knowledge and experience of people with diabetes is respected, valued and drawn upon to influence and shape diabetes care," said Corinne McCrum, Project Manager for "User involvement in local diabetes care" at Diabetes UK. "This innovative project is extremely exciting and we would encourage as many organisations as possible to apply. We strongly believe that such partnerships will help them meet their obligations to involve and lead to better care for people with diabetes." Anna Morton, Director of NHS Diabetes, said: "Service user involvement in the design and delivery of diabetes services at a local level is a core principle that underpins the work of NHS Diabetes. This innovative project will help us to make that happen, not only in the three project areas but more broadly through the lessons we learn". Further information Are you interested in being part of this project? If so, please submit this online form by 31 July 2009. You will then receive further information on the selection process. Alternatively visit our User involvement section to find out more. Diabetes UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009